179 related articles for article (PubMed ID: 31432639)
1. Human B1 Cells are the Main Blood Group A-Specific B Cells That Have a Moderate Correlation With Anti-A Antibody Titer.
Xu Y; Lee JG; Yan JJ; Ryu JH; Xu S; Yang J
Ann Lab Med; 2020 Jan; 40(1):48-56. PubMed ID: 31432639
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotyping of putative human B1 B cells in healthy controls and common variable immunodeficiency (CVID) patients.
Suchanek O; Sadler R; Bateman EA; Patel SY; Ferry BL
Clin Exp Immunol; 2012 Dec; 170(3):333-41. PubMed ID: 23121674
[TBL] [Abstract][Full Text] [Related]
3. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
4. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant.
Zhou W; Ohdan H; Tanaka Y; Hara H; Tokita D; Onoe T; Asahara T
Transpl Immunol; 2003; 12(1):9-18. PubMed ID: 14551028
[TBL] [Abstract][Full Text] [Related]
5. Potential implications of ABO blood group for vascular rejection in pig to human kidney xenotransplantation.
Oostingh GJ; Davies HF; Arch BN; Bradley JA; Taylor CJ
Xenotransplantation; 2003 May; 10(3):278-84. PubMed ID: 12694548
[TBL] [Abstract][Full Text] [Related]
6. Role of anti-A/B antibody titers in results of ABO-incompatible kidney transplantation.
Shimmura H; Tanabe K; Ishikawa N; Tokumoto T; Takahashi K; Toma H
Transplantation; 2000 Nov; 70(9):1331-5. PubMed ID: 11087148
[TBL] [Abstract][Full Text] [Related]
7. Increased but stable isoagglutinin titers in hemodialysis patients.
Assing K; Sprogoe U; Nielsen C; Rasmussen M; Yazer M; Bistrup C
J Nephrol; 2019 Feb; 32(1):121-127. PubMed ID: 30066253
[TBL] [Abstract][Full Text] [Related]
8. Differences in humoral immunity between a non-rejection group and a rejection group after ABO-incompatible renal transplantation.
Ishida H; Tanabe K; Ishizuka T; Furusawa M; Miyamoto N; Ishikawa N; Shirakawa H; Shimmura H; Ishii D; Nozaki D; Setoguchi K; Toma H
Transplantation; 2006 Mar; 81(5):665-71. PubMed ID: 16534466
[TBL] [Abstract][Full Text] [Related]
9. Development of B-cell memory in early childhood and the impact on antigen-specific tolerance after heart transplantation.
Urschel S; Ryan LA; M Larsen I; Biffis K; Dijke IE; West LJ
J Heart Lung Transplant; 2016 Apr; 35(4):491-9. PubMed ID: 26856666
[TBL] [Abstract][Full Text] [Related]
10. Application of flow cytometry to measure anti-A/B antibody in ABO-incompatible kidney transplantation.
Kim HJ; Jung HY; Choi JY; Cho JH; Park SH; Kim YL; Kim HK; Huh S; Won DI; Kim CD
Transplant Proc; 2015 Apr; 47(3):591-5. PubMed ID: 25891693
[TBL] [Abstract][Full Text] [Related]
11. Anti-gal A/B, a novel anti-blood group antibody identified in recipients of abo-incompatible kidney allografts.
Galili U; Ishida H; Tanabe K; Toma H
Transplantation; 2002 Dec; 74(11):1574-80. PubMed ID: 12490791
[TBL] [Abstract][Full Text] [Related]
12. Comparative Evaluation of Five Different Methods of Anti-ABO Antibody Titration: An Aid for ABO-Incompatible Organ Transplants.
Nayak S; Makroo RN; Prakash B; Chandra T; Agrawal S; Chowdhry M; Mohapatra A
Ther Apher Dial; 2019 Feb; 23(1):86-91. PubMed ID: 30125463
[TBL] [Abstract][Full Text] [Related]
13. ABO-incompatible living-donor kidney transplantation in children.
Shishido S; Asanuma H; Tajima E; Hoshinaga K; Ogawa O; Hasegawa A; Honda M; Nakai H
Transplantation; 2001 Sep; 72(6):1037-42. PubMed ID: 11579297
[TBL] [Abstract][Full Text] [Related]
14. Long-term desensitization for ABO-incompatible living related kidney transplantation recipients with high refractory and rebound anti-blood type antibody: case report.
Nishimura H; Yamada Y; Hisano S; Mitsuke A; Tatarano S; Gotanda T; Hayami H; Nakagawa M; Enokida H
BMC Nephrol; 2018 Oct; 19(1):254. PubMed ID: 30290778
[TBL] [Abstract][Full Text] [Related]
15. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of theefficacy of removal of anti-ABO and anti-gal antibodies by double filtration plasmapheresis.
Kobayashi T; Yokoyama I; Morozumi K; Nagasaka T; Hayashi S; Uchida K; Takagi H; Nakao A
Xenotransplantation; 2000 May; 7(2):101-8. PubMed ID: 10961294
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of the conventional tube test and column agglutination technology for ABO antibody titration in healthy individuals: a report from India.
Datta SS; Basu S; Reddy M; Gupta K; Sinha S
Immunohematology; 2021 Mar; 37(1):25-32. PubMed ID: 33962486
[TBL] [Abstract][Full Text] [Related]
18. Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis.
Sawada T; Fuchinoue S; Teraoka S
Transplantation; 2002 Nov; 74(9):1207-10. PubMed ID: 12451255
[TBL] [Abstract][Full Text] [Related]
19. Removal of anti-A/B antibodies for successful kidney transplantation between ABO blood type incompatible couples.
Tanabe K; Takahashi K; Agishi T; Toma H; Ota K
Transfus Sci; 1996 Sep; 17(3):455-62. PubMed ID: 10163554
[TBL] [Abstract][Full Text] [Related]
20. ABO-incompatible kidney transplantation: first cases in Turkey.
Tuncer M; Yücetin L; Tekin S; Demirbas A
Transplant Proc; 2012; 44(6):1703-5. PubMed ID: 22841248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
